Patents expiring in 2036

US 9492477

Compositions comprising citrate and applications thereof

The Board of Regents of the University of Texas System · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9492452

Methods and compositions for inhibition of polymerase

BioCryst Pharmaceuticals, Inc. · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9492443

Abuse deterrent compositions and methods of making same

Acurx Pharmaceuticals, Inc. · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9492433

Pharmaceutical composition for the treatment of Duchenne muscular dystrophy

Summit Corporation Plc · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9492430

Methods and compositions associated with the granulocyte colony-stimulating factor receptor

Ligand Pharmaceuticals Incorporated · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9492415

Methods of treating Parkinson's disease using viral vectors

The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9492439

Amido compounds as RORγt modulators and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9492378

Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9491934

Regulation of endogenous gene expression in cells using zinc finger proteins

Sangamo Biosciences, Inc. · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9492405

Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9492480

Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9492538

Isolation and use of solid tumor stem cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9492564

Dual specific immunotoxin for brain tumor therapy

The United States of America as Represented by the Secretary of Health and Human Services, National Institutes of Health · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9493432

Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders

Takeda Pharmaceutical Company Limited · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9493496

Algin oligosaccharides and the derivatives thereof as well as the manufacture and the use of the same

OCEAN UNIVERSITY OF CHINA · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9493552

Therapeutic biologic for treatment of hepatocellular carcinoma

China Synthetic Rubber Corporation · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9493564

CD86 antagonist multi-target binding proteins

Aptevo Research and Development LLC · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9493757

Modified factor VII or factor VIIa polypeptides

Regents of the University of Minnesota · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 3093014

CABAZITAXEL UND DESSEN VERWENDUNG ZUR BEHANDLUNG VON KREBS

AVENTIS PHARMA SA [FR] · Granted Wed Nov 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Nov 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9498471

Use of CDK9 inhibitors to reduce cartilage degradation

The Regents of the University of California · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9498526

Human rotavirus vaccine strains and diagnostics

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9502711

Fabrication of biscrolled fiber using carbon nanotube sheet

The Board of Regents of the University of Texas System · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499667

Biodegradable surfactant, preparation method and use thereof

GAINIA (SHANGHAI) PATENT TECHNOLOGY LTD. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499868

Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499821

Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9498571

Nitric oxide delivery devices

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9497945

Humanized dipeptidyl peptidase IV (DPP4) animals

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9498432

Injectable flowable composition comprising buprenorphine

Indivior UK Limited · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9498479

Dihydropyrimidine compounds and their application in pharmaceuticals

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9498511

Methods related to the treatment of neurodegenerative and inflammatory conditions

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499494

Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis

Northwestern University · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499495

Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

Asana BioSciences, LLC · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9498468

Rhinitis treatment regimens

Pharmaceutical Design, LLC · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499568

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499554

Anti-influenza compositions and methods

BioCryst Pharmaceuticals, Inc. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499608

Bispecific monoclonal antibody therapeutics against West Nile virus with improved CNS penetration

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499487

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499493

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499818

Methods and means for efficient skipping of at least one of the exons 51-53, 55, 57 and 59 of the human duchenne muscular dystrophy gene

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9498533

Drug delivery compositions and methods

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9498537

Method of enhancing efficacy of blood transfusions

The Regents of the University of California · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9498566

Selective cytopheresis devices and related methods thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9498529

Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9498544

Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents

Tissue Regeneration Therapeutics Inc. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499588

Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499597

Methods and compositions for treating Huntington's disease

Sangamo Biosciences, Inc. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499583

Antibacterial antisense oligonucleotide and method

Sarepta Therapeutics, Inc. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9499595

Development of influenza A antivirals

The Board of Regents of the University of Texas System · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)